Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.7035
H.R.7035: Biologics Market Transparency Act of 2022
About This Bill
- This bill was introduced in the 117th Congress
- This bill is primarily about health
- Introduced March 9, 2022
- Latest Major Action March 10, 2022
Bill Sponsor
Bill Cosponsor
Bill Version
- Introduced in House - March 9, 2022
Bill Summary
Biologics Market Transparency Act of 2022 This bill requires biologics manufacturers to notify the Food and Drug Administration in advance of withdrawing a product from sale.
(Source: Library of Congress)
What Lawmakers Are Saying About This Bill
Bill Actions
Date | Description |
---|---|
March 10, 2022 |
Referred to the Subcommittee on Health.
|
March 9, 2022 |
Referred to the House Committee on Energy and Commerce.
|
March 9, 2022 |
Introduced in the House by Kathy Manning (D-N.C.) |